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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A382as meniscal progenitor cells (MPC) derived from diseased human
meniscus. Also osteoarthritic cartilage of DDR-1-deﬁcient mice harbors
a progenitor cell population.
Conclusions: Taken together, we propose that speciﬁc progenitor cell
populations found in situ are responsible for tissue regeneration in a
wide variety of cartilage tissues in humans andwill be of importance for
cell biological therapeutic interventions in osteoarthritis.
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Purpose:We are studying the cell based- and pharmaceutical-
approaches for cartilage repair, combined with surgical bone marrow
stimulation technique to supply the cells contributing to wound heal.
Bone marrow tissue has heterogeneous cell-populations, including
hematopoietic stem cells, and we prefer to enhance the cells with as
better chondrogenic ability as possible in order to promote cartilage
repair process. It has been known that direct intra-articular injection of
basic ﬁbroblast growth factor (bFGF) promotes articular cartilage repair
of osteochondral defect in animal model, however bFGF also has an
unfavorable action for clinical application, osteophyte formation. In
vitro studies have shown that the supplementation of bFGF for human
bone marrow derived mesenchymal stem cells (hBMSCs) during
expansion phase maintains the chondrogenic potential as well as
enhance their proliferation. However, the population of hBMSCs sup-
plemented with bFGF has not been investigated enough yet. This study
aimed to analyze some characters, size and MSC markers, of the pop-
ulation of hBMSCs with bFGF.
Methods: Bone marrow aspirates were obtained from healthy donors
by routine iliac crest aspiration with their agreement and seeded to
culture ﬂasks, mixed with 2-fold volume of growth medium containing
15% lot adjusted FBS, supplemented with or without 10ng/ml bFGF
(PeproTech, NJ, USA ). Non-adherent cells were removed at 3days and
culture medium was changed every 3 days. At 11 to 14 days, P0 end,
hBMSCs were passed to P1 and cultured with 5% FBS containing growth
medium, keeping the condition of bFGF. The P1 cells were prepared for
immunocytochemistry and for the conﬁrmation of the chondrogenic
ability. The size of the cells was measured with the automated Coulter
cell counter at the end of P0 and P1. For immunocytochemistry, the cells
at day4 on P1 stage were ﬁxed with 4% PFA, and then Endoglin on cell
surface were stained. The cells harvested at P1 end were used to per-
form pellet culture for 21 days. The histology sections of the pellets
were stained with Safranin-O/Fast green, and the glycosaminoglycan
(GAG) contents were measured and normalized with DNA (GAG/DNA),
to evaluate their chondrogenic ability. The data of two groups, with or
without bFGF on P0 and P1, were compared using unpaired t-test.
Statistical tests were considered signiﬁcant at the level of P < 0.05.
Results: The size of the bFGF supplemented-hBMSCs was signiﬁcantly
smaller than hBMSCs without bFGF at P0 and P1, both. Most of the cells
regardless with bFGF supplementation were expressed Endoglin,
however bFGF supplemented-hBMSCs seemed to express Endoglin
more. The pellets from the cells expanded with bFGF were bigger and
histology of them showed Safranin-O stained more and contained more
GAG/DNA than another as previously reported.
Conclusions: The population of hBMSCs supplemented with bFGF has
some distinct characters, smaller size and probably more expression of
Endoglin than hBMSCs without bFGF. Endoglin has been reported as an
accessory receptor for transforming growth factor-b (TGF-b) and might
modulate the downstream signal molecules, such as smad-1/5/8, of
hBMSCs. Gene expression level of Endoglin needs to be measured, and
other MSC markers as well are going to be investigated. The cells
involving in the cartilage repair would be characterized more, and if we
could target and enhance this kind of the cells with any other agent
than bFGF during cartilage repair process, better cartilage repair might
be acquired.Synovial Tissue Biology & Biochemistry
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PATIENTS WITH PROGRESSION OF CARTILAGE DAMAGE AND
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Purpose: Over 50% of osteoarthritis (OA) patients show synovial
inﬂammation, even relatively early during the disease. However, if and
how this synovial activation contributes to the irreversible joint path-
ology that characterizes OA, is not known. In the present study we used
microarray analysis of unique synovial tissue samples of early OA
patients and of experimental OA, to identify common pathways that
may determine progression of cartilage damage and osteophyte for-
mation in this disease.
Methods: From 25 patients with knee OA that entered the CHECK
Cohort study Cohort Hip and Cohort Knee) and 6 controls, synovial
biopsies were collected at baseline. CHECK is a prospective 10-year
follow-up study on patients with early osteoarthritis-related com-
plaints initiated by the Dutch Arthritis Association. At baseline and
follow-up, highly standardized radiographs were taken, and analyzed
using the KIDA (Knee Image Digital Analysis) system. Progression was
determined based on change of joint space width (JSW) and osteophyte
size in radiographs, as analyzed using the KIDA (Knee Image Digital
Analysis) system. Synovial samples from baseline were studied using
histology and affymetrix U133-plus-2.0 chips, which were analyzed
using Partek Genomics Suite software and Functional Annotation
Clustering (FAC) was done using DAVID.
Results:Upon histological examination at baseline, we found that lining
thickness and synovitis were enhanced in the CHECK biopsies com-
pared to control synovia. Gene expression proﬁles of control synovia
were compared to our unique set of CHECK synovia. FAC analysis
indicated enrichment of several biological processes and signaling
pathways, including regulation of macrophage differentiation, innate
immune responses, cell migration, TGFb-, BMP- and wnt-signaling. This
indicates activation of the synovium in the CHECK patients compared to
controls. To determine whether any of the regulated genes and path-
ways were predictive for progression of joint damage between baseline
and t¼5, we identiﬁed 13 patients that were marked progressors and
non-progressors, based on JSW (respectively n¼13 vs n¼8) or osteo-
phyte size (respectively n¼10 vs n¼11) at these time points. At baseline,
neither minimum JSW nor osteophyte size differed between the groups.
Approximately 200 genes were expressed more than 2-fold higher in
synovium of osteophyte-progressors, and approximately 100 genes in
the group of JSW-progressors. Among the genes that were differentially
expressed by osteophyte progressors were MMP1, 2, 3, 9 and -14,
whereas in JSW-progressors onlyMMP1was differentially expressed. In
the group of JSW-progressors, macrophage markers like CD14, S100A8,
S100A9, MHC class II genes, and Cxcr2 were positively associated with
progression. This indicates that expression of these factors may predict,
or even be involved in, progression of cartilage damage in OA patients.
The osteophyte-progressors also showed an increase of most of these
markers, but to a far lesser extent. Using FAC we identiﬁed inﬂamma-
tory response, macrophage differentiation, blood vessel formation,
ossiﬁcation and cell migration to be enriched in patients that show
progression of joint space narrowing 5 years later. Blood vessel for-
mation, wound healing, ossiﬁcation and cell proliferation were
enriched in osteophyte-progressors. Histologically, the JSW-progressors
showed a higher thickness of the lining layer and a higher cellularity in
the sublining compared to non-progressors, and compared to osteo-
phyte progressors. Both JSW-progressors and osteophyte-progressors
showed increased vascularisation compared to non-progressors.
Conclusions: These data suggest an active role for the synovium in OA
pathology, and identiﬁes pathways that are likely to be involved. We
found evidence for e difference in underlying processes in the synovium
regarding progression of cartilage damage and progression of osteo-
phyte formation. Fromhistology and the expression data, it appears that
